EDF Health

Selected tag(s): Industry tactics

Scientists push back against a bill that would pervert the whole concept of conflict of interest

By Richard Denison / Published: December 7, 2012

Richard Denison, Ph.D., is a Senior Scientist.

This week, two letters – one signed by 13 prominent public health scientists and the other signed by the heads of 8 major national environmental organizations – were sent to the House Science Committee voicing strong opposition to H.R. 6564, the EPA Science Advisory Board Reform Act of 2012.

The sponsors of this legislation claim that it is needed to “enhance transparency and limit conflicts of interest” on the Environmental Protection Agency’s (EPA) Science Advisory Board (SAB) and its panels.  In fact, it would do the precise opposite.  Here’s how the scientists’ letter summarizes the impacts that would arise from passage of the bill:   

“This proposed legislation would only serve to reverse progress in bringing the best scientific advice and analysis to EPA.  The consequence would be to deprive EPA of needed scientific advice on the most complex and pressing environmental health problems of our day.” 

Among the most perverse provisions of this bill (and there are many) are two that would turn the very notion of conflict of interest on its head.  One would limit scientists that receive competitive grants through EPA’s extramural research program from serving on the SAB or its panels – claiming that such funding constitutes a conflict of interest.  The scientists’ letter goes directly at that provision:

“The underlying idea that scientists who obtain funding from EPA for any project have conflicts about all EPA matters is baseless and reflects a misunderstanding of who we are as scientists and our role in society.”

Another provision is even more perverse:  It would reverse longstanding conflict-of-interest policy and practice followed by virtually every authoritative scientific body in the world – including the National Academy of Sciences, the International Agency for Research on Cancer and the World Health Organization – by allowing unfettered access of industry representatives with direct conflicts of interest to serve on the SAB and its panels, as long as their conflicts are disclosed.

Who’s behind this radical legislation?  Here’s a hint:  The American Chemistry Council (ACC), which represents the chemical manufacturing industry, couldn’t wait to express its unequivocal support, stating it “cannot overstate the importance of this bill to Americans” in a press release titled “House Science Committee Proposes Common Sense Reform To EPA Scientific Advisory Process:  Proposed Legislation Would Improve Expert Panel Selection, Limit Conflicts of Interest and Enhance Systematic Reviews.”  And ACC’s been singing the bill’s praises all over town ever since (see, e.g., slide 6 of this ACC presentation).  Read More »

Posted in Health policy, Industry influence, TSCA reform / Also tagged , , , | Comments are closed

Small is beautiful: Polling shows huge bipartisan support for TSCA reform among small business owners

By / Published: November 16, 2012

Alissa Sasso is a Chemicals Policy Fellow.

This week, the American Sustainable Business Council released the results of a bipartisan national survey of 511 small business owners conducted by Lake Research Partners and Public Opinion Strategies. The survey showed that small business owners, just like voters, support stronger chemical safety regulations to mitigate the risks posed to human health and the environment by toxic chemicals.

Small business owners are an important part of the discussion on TSCA reform; the chemical industry frequently uses this group as an excuse to oppose tighter regulations, claiming that these regulations are “bad for business” and would detrimentally harm small business owners. In contrast, the survey shows that there is broad consensus among small business owners on the need to ensure the safety of their products and their customers.  Read More »

Posted in Health policy, TSCA reform / Also tagged , , , | Comments are closed

Joe Chemical — Ring a bell?

By Richard Denison / Published: June 13, 2012

Richard Denison, Ph.D., is a Senior Scientist.

I’ve blogged earlier about the chemical industry’s campaign of deception exposed by the Chicago Tribune last month in a jaw-dropping series titled “Playing with Fire.”  That in-depth series ran into the tens of thousands of words and included many extras such as video interviews.

EDF and the Safer Chemicals Healthy Families coalition decided it should be boiled down to its essence.  That’s why we produced this ad, which is running full page today in Politico:

[click to enlarge]

For more on this, check out www.saferchemicals.org/JoeChemical.

 

Posted in Health policy, Industry influence, TSCA reform / Also tagged , , | Comments are closed

Labor and public health advocates to the chemical industry: Stop bullying federal scientists!

By Richard Denison / Published: May 21, 2012

Richard Denison, Ph.D., is a Senior Scientist.

After my long post this morning, I’ll keep this one brief:  The United Steelworkers, one of the nation’s top occupational physicians and EDF, represented by Earthjustice, have filed a motion to intervene in D.C. District Court, seeking to help defend the U.S. Department of Health and Human Services’ listing of styrene as “reasonably anticipated to be a human carcinogen.”  The motion is in response to a chemical industry lawsuit attempting to force the agency’s National Toxicology Program to withdraw the styrene warning, which was published in the 12th edition of the Congressionally mandated Report on Carcinogens.

Posted in Health policy, Industry influence, TSCA reform / Also tagged , , | Comments are closed

No shame: ACC plunges to new low in fighting your right to know

By Richard Denison / Published: May 21, 2012

Richard Denison, Ph.D., is a Senior Scientist.

This post is longer than usual and starts with a rather esoteric topic, but I urge you to read it through, as it vividly shows there is no limit to the lengths to which the American Chemistry Council (ACC) will go to squirm out of a regulatory requirement, even if it means violating rules by which ACC had agreed to abide.

But that’s far from the worst of it.  Going farther than even I could imagine when I blogged earlier about its tactics, ACC is sparing no effort to deny your right to know about the health impacts of chemicals, by mustering every argument it can invent – however far-fetched – to  keep health and safety studies from being shared with the public.

ACC insists that the U.S. Environmental Protection Agency (EPA) should hassle the European Union (EU) instead of its members for the health and safety data ACC promised to provide – despite the fact that the chemical industry itself has thrown up major roadblocks to such sharing.  And reaching a new low in tortured logic, ACC argues that, should EPA succeed in getting its hands on the health and safety data submitted to the EU, EPA can and should deny the public access to those data – despite the fact that the Toxic Substances Control Act (TSCA) clearly prohibits EPA from withholding such information.  Read More »

Posted in Health policy, Industry influence, Regulation / Also tagged , , , , , | Comments are closed

ACC missing in action this week, no doubt feeling burned

By Richard Denison / Published: May 10, 2012

Richard Denison, Ph.D., is a Senior Scientist.

Every day in my email I get the American Chemistry Council’s (ACC’s) “SmartBrief,” a digest of the day’s news related to the chemical industry.  Here’s its self-description:

Designed specifically for American chemistry professionals, ACC SmartBrief is a FREE, daily e-mail news briefing. It provides the latest news and information on the American chemistry industry.

As I noted in my last blog post, all this week the Chicago Tribune has been running one of the biggest stories relating to the chemical industry published in a long, long time.  Titled “Playing with Fire,” it documents in meticulous detail the campaign of deception that producers of chemical flame retardants have foisted on the American public for decades.

One might expect, therefore, that ACC’s SmartBrief this week would be directing its readers – who sign up to keep up with what they need to know that affects the chemical industry – to the Tribune’s series.  One would be wrong.  Nary a mention of this blockbuster story managed to find its way into SmartBrief this week.

It appears that only certain news relevant to SmartBrief’s audience of American chemistry professionals is deemed essential enough to make the cut over at ACC.  SmartBrief readers might need to look elsewhere if they want to know what’s really affecting their industry.

In fact, the only response to be found anywhere on ACC’s website to this week’s major news is this highly oblique press release posted there yesterday.  It makes no mention of the Tribune series, but does affirm the industry’s commitment to safety as a general matter.  And it includes this tidbit:

ACC always strives to conduct its advocacy work in an open and transparent manner.

Oh really?

Posted in Health science / Also tagged , , | Comments are closed